Streetbeat News

Equity Actions

XYF

X Financial (NYSE: XYF) has initiated a tender offer to buy back up to 2 million of its American Depositary Shares (ADSs) at $4.52 per ADS. This move is part of a previously approved $20 million share repurchase program. The tender offer will expire on July 12, 2024.

Portfolio Pulse from Benzinga Newsdesk

June 05, 2024 | 1:14 pm

VLCN

Volcon shares are trading lower after the company announced a 1-for-100 reverse stock split.

Portfolio Pulse from Benzinga Newsdesk

June 05, 2024 | 1:01 pm

CRKN

Crown Electrokinetics shares are trading lower following the announcement of an offering of 300 million shares of its common stock by Keystone Capital Partners.

Portfolio Pulse from Benzinga Newsdesk

June 05, 2024 | 12:50 pm

CRKN

Crown Electrokinetics has filed a prospectus for the potential resale of up to 300 million shares of common stock by Keystone Capital Partners. This filing was made with the SEC.

Portfolio Pulse from Benzinga Newsdesk

June 05, 2024 | 12:45 pm

SILO

Silo Pharma shares are trading lower following the announcement of a $2 million registered direct offering.

Portfolio Pulse from Benzinga Newsdesk

June 05, 2024 | 12:41 pm

VLCN

Volcon Inc. (NASDAQ:VLCN) announced a 1-for-100 reverse stock split, effective June 6, 2024. The stock will trade on a post-split basis on Nasdaq starting June 7, 2024, under the same ticker symbol but with a new CUSIP number.

Portfolio Pulse from Benzinga Newsdesk

June 05, 2024 | 12:22 pm

AKTX

Akari Therapeutics Plc (NASDAQ:AKTX) has announced that Samir R. Patel, M.D., has assumed the role of Interim President & CEO and has increased his ownership to 14.2% with a $1.25M investment in a recent private placement. Dr. Patel's employment contract consists solely of equity compensation, aligning his success with that of the company's shareholders.

Portfolio Pulse from Benzinga Newsdesk

June 05, 2024 | 12:11 pm

ANNX

Annexon shares are trading lower following the announcement of a $125 million public offering.

Portfolio Pulse from Benzinga Newsdesk

June 05, 2024 | 12:07 pm

SILO

Silo Pharma has entered into agreements for the purchase and sale of 917,432 shares at $2.18 per share in a registered direct offering, resulting in gross proceeds of $2 million.

Portfolio Pulse from Benzinga Newsdesk

June 05, 2024 | 12:06 pm

AGL

Agilon Health (NYSE: AGL) has appointed Jeff Schwaneke as the new CFO, effective July 1, 2024. Schwaneke, who is currently a director on Agilon's board, will succeed Timothy Bensley, who is retiring in early 2024 but will stay on through a transition period.

Portfolio Pulse from Benzinga Newsdesk

June 05, 2024 | 12:01 pm